Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MICHELLE M MANGUAL GARCIA

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1518292960
CMS profile
605795
Location
SAN JUAN, PR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$9,431.76

123 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 3 of 3; records 101–123 of 123 matching records. This page contains 23 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MICHELLE M MANGUAL GARCIA

NPI 1518292960 · CMS profile ID 605795

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

SAN JUAN, PR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–123 of 123 matching records. This page contains 23 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1518292960?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MICHELLE M MANGUAL GARCIA, NPI 1518292960, CMS profile ID 605795. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–123 of 123 matching records. This page contains 23 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1518292960?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). MICHELLE M MANGUAL GARCIA, NPI 1518292960, CMS profile ID 605795. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–123 of 123 matching records. This page contains 23 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1518292960?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
MICHELLE M MANGUAL GARCIA, NPI 1518292960, CMS profile ID 605795, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–123 of 123 matching records. This page contains 23 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1518292960?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

123 matching records · $9,431.76 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 123 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–123 of 123.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Boehringer Ingelheim Pharmaceuticals, Inc. $19.4704/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763645782 CMS
Corcept Therapeutics $124.9204/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837525211 CMS
Novo Nordisk Inc $20.0004/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810857395 CMS
AstraZeneca Pharmaceuticals LP $100.0004/01/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829992201 CMS
Abbott Laboratories $19.7803/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818457101 CMS
Eli Lilly Export S.A. Puerto Rico Branch $20.0003/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 860806249 CMS
Lilly USA, LLC $650.0003/25/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818590989 CMS
Amgen Inc. $125.0003/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825629089 CMS
AstraZeneca Pharmaceuticals LP $14.9903/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829341149 CMS
DEXCOM, INC. $20.7803/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845287715 CMS
SANOFI-AVENTIS U.S. LLC $21.8202/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843655369 CMS
PBG PUERTO RICO LLC $20.9102/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833089423 CMS
SANOFI-AVENTIS U.S. LLC $20.0002/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843655379 CMS
Novo Nordisk Inc $20.0002/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811239299 CMS
Lilly USA, LLC $650.0002/11/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818606019 CMS
AstraZeneca Pharmaceuticals LP $14.8902/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829530641 CMS
Amgen Inc. $125.0002/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825629105 CMS
Eli Lilly Export S.A. Puerto Rico Branch $21.4902/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818651883 CMS
Lilly USA, LLC $325.0001/27/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818671267 CMS
SANOFI-AVENTIS U.S. LLC $20.0001/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843655367 CMS
Merck Sharp & Dohme Corporation $17.1501/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848360497 CMS
AstraZeneca Pharmaceuticals LP $14.9401/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829794267 CMS
Medtronic, Inc. $13.5301/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815564567 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $30,159.86 119
PY2020 $28,846.54 115
PY2021 $9,431.76 123
PY2022 $4,367.94 124
PY2023 $3,624.07 116
PY2024 $4,522.33 111
PY2025 $6,264.80 85

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $250,100.99 31
PY2024 Recipient $2,900.00 1
PY2024 Principal investigator $72,253.88 9
PY2023 Principal investigator $39,334.07 2
PY2022 Recipient $3,999.00 2
PY2022 Principal investigator $121,084.00 2
PY2021 Recipient $6,344.47 2
PY2021 Principal investigator $173,453.00 2
PY2020 Recipient $1,472.58 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

31 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $5,612.00 12/31/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR GROUP
A Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism No dispute reported 06/30/2026 1202534469
Principal investigator 1 ABBVIE INC. $34,575.17 12/05/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202529452
Principal investigator 1 ABBVIE INC. $26,693.23 11/05/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202521659
Principal investigator 1 ABBVIE INC. $488.70 09/26/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202512528
Principal investigator 1 ABBVIE INC. $74,526.77 09/24/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202512120
Principal investigator 1 ABBVIE INC. $1,102.95 08/14/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202504753
Principal investigator 1 ABBVIE INC. $870.75 08/14/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202504899
Principal investigator 1 ABBVIE INC. $445.50 08/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202503865
Principal investigator 1 ABBVIE INC. $445.50 08/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202503869
Principal investigator 1 ABBVIE INC. $1,987.20 08/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202503871
Principal investigator 1 ABBVIE INC. $1,458.00 08/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202503875
Principal investigator 1 ABBVIE INC. $415.80 08/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202504001
Principal investigator 1 ABBVIE INC. $445.50 08/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202504003
Principal investigator 1 ABBVIE INC. $2,632.50 08/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202504005
Principal investigator 1 ABBVIE INC. $972.00 08/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202504007
Principal investigator 1 ABBVIE INC. $237.60 08/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202504009
Principal investigator 1 ABBVIE INC. $302.40 07/28/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202500140
Principal investigator 1 ABBVIE INC. $637.20 07/28/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202500142
Principal investigator 1 ABBVIE INC. $1,150.20 07/28/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202500144
Principal investigator 1 ABBVIE INC. $1,533.60 07/28/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202500146
Principal investigator 1 ABBVIE INC. $15,175.79 07/03/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202496749
Principal investigator 1 ABBVIE INC. $21,027.08 06/03/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202488149
Principal investigator 1 ABBVIE INC. $9,362.95 05/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202483207
Principal investigator 1 ABBVIE INC. $4,162.06 04/03/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202472504
Principal investigator 1 ABBVIE INC. $1,696.20 04/02/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202468434
Principal investigator 1 ABBVIE INC. $3,375.00 04/01/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202467897
Principal investigator 1 ABBVIE INC. $8,822.39 03/07/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202461330
Principal investigator 1 ABBVIE INC. $4,226.32 02/06/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202449381
Principal investigator 1 Eli Lilly and Company $570.45 01/27/2025 Non-covered Recipient Entity
MEDICAL EDUCATION & RESEARCH FOUNDATION INC
THE EFFECT OF TIRZEPATIDE VERSUS DULAGLUTIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES (SURPASS CVOT) No dispute reported 06/30/2026 1187886510
Principal investigator 1 Eli Lilly Export S.A. Puerto Rico Branch $23,533.00 01/21/2025 Non-covered Recipient Entity
MEDICAL EDUCATION & RESEARCH FOUNDATION INC
THE EFFECT OF TIRZEPATIDE VERSUS DULAGLUTIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES (SURPASS CVOT) No dispute reported 06/30/2026 1187887188
Principal investigator 1 ABBVIE INC. $1,617.18 01/02/2025 Non-covered Recipient Entity
CLINICAL RESEARCH INVESTIGATOR
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202435611